BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 16819510)

  • 1. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence.
    Kamps MP; Wright DD
    Oncogene; 1994 Nov; 9(11):3159-66. PubMed ID: 7936638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
    Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
    Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
    Calvo KR; Knoepfler P; McGrath S; Kamps MP
    Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation.
    Kamps MP; Wright DD; Lu Q
    Oncogene; 1996 Jan; 12(1):19-30. PubMed ID: 8552391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2.
    Smith KS; Jacobs Y; Chang CP; Cleary ML
    Oncogene; 1997 Jun; 14(24):2917-26. PubMed ID: 9205098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia.
    Bijl J; Krosl J; Lebert-Ghali CE; Vacher J; Mayotte N; Sauvageau G
    Oncogene; 2008 Oct; 27(49):6356-64. PubMed ID: 18679416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role for a single leucine residue in leukemia induction by E2A-PBX1.
    Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP
    Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
    de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
    Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation.
    Knoepfler PS; Sykes DB; Pasillas M; Kamps MP
    Oncogene; 2001 Sep; 20(39):5440-8. PubMed ID: 11571641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
    Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
    Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.
    Bijl J; Sauvageau M; Thompson A; Sauvageau G
    Genes Dev; 2005 Jan; 19(2):224-33. PubMed ID: 15655112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
    Sykes DB; Kamps MP
    Mol Cell Biol; 2004 Feb; 24(3):1256-69. PubMed ID: 14729970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
    Houston IB; Huang KJ; Jennings SR; DeKoter RP
    Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains.
    LeBrun DP; Matthews BP; Feldman BJ; Cleary ML
    Oncogene; 1997 Oct; 15(17):2059-67. PubMed ID: 9366523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors.
    Woodcroft MW; Nanan K; Thompson P; Tyryshkin K; Smith SP; Slany RK; LeBrun DP
    PLoS One; 2015; 10(6):e0130495. PubMed ID: 26098938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression.
    Hassawi M; Shestakova EA; Fournier M; Lebert-Ghali CÉ; Vaisson G; Frison H; Sinnett D; Vidal R; Thompson A; Bijl JJ
    Dev Dyn; 2014 Jan; 243(1):145-58. PubMed ID: 23996689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
    Casagrande G; te Kronnie G; Basso G
    Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage differentiation of myeloid progenitor cells in response to M-CSF is regulated by the dual-specificity phosphatase DUSP5.
    Grasset MF; Gobert-Gosse S; Mouchiroud G; Bourette RP
    J Leukoc Biol; 2010 Jan; 87(1):127-35. PubMed ID: 19801501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.